Attys Denied Fee Set-Aside In Generics Antitrust Case
By Christopher Cole · October 8, 2019, 5:03 PM EDT
Lawyers for two sets of litigants suing generic-drug makers in a price-fixing class action can't get a 10% set-aside from any future damages that parties taking their own direct actions ultimately...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login